Source:http://linkedlifedata.com/resource/pubmed/id/10917135
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-10-20
|
pubmed:abstractText |
Because in experimental hepatocarcinogenesis apoptosis increases from normal to preneoplastic to carcinoma tissue, proapoptotic factors, such as activin-A, may represent useful markers for hepatocellular carcinoma (HCC). In this study, serum activin-A was measured in 99 cirrhotic patients, of whom 55 had HCC. Activin-A concentrations were higher in HCC patients (median, 2.33 ng/ml; range, 0.41-8.12) than in patients with nonmalignant cirrhosis (1.28 ng/ml; range, 0.35-6.25) (P < .05). All 12 patients with activin-A greater than 3 ng/ml and serum alpha-fetoprotein greater than 30 ng/ml had HCC, in comparison to 32 of 41 patients who had only one and to 11 of 46 patients who had both markers below these cutoffs (P < .0001). No correlation was found between activin-A and alpha-fetoprotein in the two groups, whereas in patients with HCC, activin-A was strictly correlated with serum aspartate aminotransferase (P < .001). Activin-A mRNA for inhibin betaA subunit was expressed both in tumor and nontumor liver tissues in a case of HCC superimposed on cirrhosis and was not expressed in a case of HCC without cirrhosis. In conclusion, cirrhotic patients with HCC have high serum activin-A, to the production of which both the cirrhotic liver and the liver tumor are likely to contribute.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Activins,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Prostatic Secretory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Fetoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/beta-microseminoprotein
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0361-090X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
150-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10917135-Activins,
pubmed-meshheading:10917135-Adult,
pubmed-meshheading:10917135-Aged,
pubmed-meshheading:10917135-Aged, 80 and over,
pubmed-meshheading:10917135-Aspartate Aminotransferases,
pubmed-meshheading:10917135-Biological Markers,
pubmed-meshheading:10917135-Carcinoma, Hepatocellular,
pubmed-meshheading:10917135-Female,
pubmed-meshheading:10917135-Humans,
pubmed-meshheading:10917135-Inhibins,
pubmed-meshheading:10917135-Liver Cirrhosis,
pubmed-meshheading:10917135-Liver Neoplasms,
pubmed-meshheading:10917135-Male,
pubmed-meshheading:10917135-Middle Aged,
pubmed-meshheading:10917135-Peptides,
pubmed-meshheading:10917135-Prostatic Secretory Proteins,
pubmed-meshheading:10917135-RNA, Messenger,
pubmed-meshheading:10917135-alpha-Fetoproteins
|
pubmed:year |
2000
|
pubmed:articleTitle |
Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma.
|
pubmed:affiliation |
DPMSC, Cattedra di Ostetricia e Ginecologia, University of Udine, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|